Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102199103B details an improved L-thyroxine sodium synthesis via oxidative coupling. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN105541953B details a recrystallization method achieving high purity without column chromatography, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN115197115A details a novel chiral synthesis route offering high optical purity and scalable manufacturing for pharmaceutical intermediates and cost reduction.
Patent CN107540648A reveals a novel route for Dapagliflozin offering high purity and safety. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Patent CN101475572A reveals a high-purity synthesis route for triacetylganciclovir using monoacetylguanine, offering significant cost reduction and scalability for API manufacturing.
Patent CN107987053B details a novel isomerization process for Z-type flupenthixol hydrochloride, offering enhanced purity and supply chain stability for pharmaceutical manufacturing.
Novel five-step synthesis route for 10-methoxyiminostilbene offers mild conditions and high purity. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN104987338A reveals a low-cost method for Sitagliptin phosphate key intermediate. Achieve high purity and supply chain stability with optimized Grignard processes.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN105254587A details a safer chlorination route for tianeptine sodium intermediate using industrial hydrochloric acid, ensuring high purity and supply chain stability.
Novel catalytic hydrogenation process for high-purity 2-amino-2-arylethanols using Raney nickel. Offers significant cost reduction and scalability for pharmaceutical intermediates.
Novel solid-phase secondary cyclization method for plecanatide ensures high purity and yield. Offers significant supply chain advantages for pharmaceutical intermediates manufacturing.
Advanced hybrid synthesis patent CN106589069B ensures high purity oxytocin. Reduces costs and improves supply chain reliability for pharmaceutical manufacturers globally.
Advanced patent CN119080860A details a novel refining method for 17α-hydroxyprogesterone ensuring high purity and yield for scalable pharmaceutical intermediates manufacturing supply chains.
Novel solid-phase method using ester-bond transamidation improves purity and yield for GLP-1 analogs. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN111732649B details continuous flow solid-phase synthesis for liraglutide, offering high purity, reduced solvent use, and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN116836046B enables high-purity 4-Biphenylformaldehyde production. Achieve cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Enzymatic synthesis patent CN100396782C offers high purity stable isotope labeled amino acids with streamlined extraction and superior 15N utilization for research.